ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,902Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 267

$466K Total Retail Price of All Prescriptions

Rank: 31 out of 267

492 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in North Dakota
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 492 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
FUROSEMIDE 451 420 75 1 4
LISINOPRIL 361 330 55 2 3
POTASSIUM CHLORIDE 354 331 58 3 10
OMEPRAZOLE 342 304 70 4 5
LEVOTHYROXINE SODIUM 324 274 59 5 2
AMLODIPINE BESYLATE 310 280 55 6 6
METOPROLOL TARTRATE 286 264 45 7 8
ATORVASTATIN CALCIUM 271 245 42 8 9
SIMVASTATIN 229 217 39 9 1
WARFARIN SODIUM 217 190 33 10 13
HYDROCHLOROTHIAZIDE 198 198 29 11 7
METFORMIN HCL 165 160* 31 12 12
FENTANYL 162 162 15 S2 13 42
ALLOPURINOL 156 138 23 14 22
SERTRALINE HCL 156 137 24 14 14
GABAPENTIN 152 147* 23 16 17
NAMENDA 152 <11 <11 16 31
METOPROLOL SUCCINATE 147 142* 22 18 11
LORAZEPAM 131 126* 45 B 19 26
QUETIAPINE FUMARATE 130 118 17 A 20 51
TAMSULOSIN HCL 129 116 25 21 24
DONEPEZIL HCL 127 127 18 22 21
DIOVAN 124 119* 13 23 58
ATENOLOL 119 107 22 24 18
TRAMADOL HCL 114 109* 36 25 19
CIPROFLOXACIN HCL 109 104* 53 26 57
NEXIUM 108 103* 12 27 61
CLOPIDOGREL 105 81 23 28 20
HYDROCODONE-ACETAMINOPHEN 101 96* 33 S3 29 15
LYRICA 96 83 12 30 70
PREDNISONE 94 94 28 31 29
ESCITALOPRAM OXALATE 93 88* 17 32 69
CRESTOR 84 <11 <11 33 28
MIRTAZAPINE 82 77* 12 34 35
LOSARTAN POTASSIUM 80 80 12 35 16
RAMIPRIL 77 72* 12 36 94
DIGOX 74 74 11 37 45
CEPHALEXIN 74 69* 44 37 82
AMOXICILLIN 73 68* 56 39 143
VESICARE 73 <11 <11 39 111
BENAZEPRIL HCL 71 71 11 41 96
POLYETHYLENE GLYCOL 3350 70 51 13 42 41
ISOSORBIDE MONONITRATE ER 70 <11 <11 42 34
CITALOPRAM HBR 68 <11 <11 44 23
VALSARTAN-HYDROCHLOROTHIAZIDE 67 67 12 45 121
ALPRAZOLAM 66 49 12 B 46 47
BYSTOLIC 66 61* 13 46 118
MELOXICAM 61 <11 <11 48 49
VENLAFAXINE HCL ER 59 <11 <11 49 68
CYMBALTA 55 <11 <11 50 54
TRIAMTERENE-HCTZ 55 <11 <11 50 39
GLIMEPIRIDE 54 <11 <11 52 48
AZITHROMYCIN 52 47* 38 53 53
JANUVIA 51 <11 <11 54 88
DOXAZOSIN MESYLATE 50 <11 <11 55 72
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.